2016
4:03 PMAbstract No. 343 3D quantification of viable tumor volume in patients with hepatocellular carcinoma predicts the hepato-pulmonary shunt fraction before Y90 radioembolization.
Collettini F, Collettini F, DoMing D, David W, Lin M, Geschwind J, Hamm B, Gebauer B, Chapiro J. 4:03 PMAbstract No. 343 3D quantification of viable tumor volume in patients with hepatocellular carcinoma predicts the hepato-pulmonary shunt fraction before Y90 radioembolization. Journal Of Vascular And Interventional Radiology 2016, 27: s155. DOI: 10.1016/j.jvir.2015.12.403.Peer-Reviewed Original Research
2013
Can C-Arm Cone-Beam CT Detect a Micro-Embolic Effect After TheraSphere Radioembolization of Neuroendocrine and Carcinoid Liver Metastasis?
Pellerin O, Lin M, Bhagat N, Shao W, Geschwind J. Can C-Arm Cone-Beam CT Detect a Micro-Embolic Effect After TheraSphere Radioembolization of Neuroendocrine and Carcinoid Liver Metastasis? Cancer Biotherapy & Radiopharmaceuticals 2013, 28: 459-465. PMID: 23484809, PMCID: PMC3715773, DOI: 10.1089/cbr.2012.1390.Peer-Reviewed Original ResearchConceptsTumor enhancementHounsfield unitsArterial phaseCapillary levelCarcinoid liver metastasesYttrium-90 microspheresHigh-dose radiationEarly arterial phaseContrast medium injectionC-arm cone-beam CTTheraSphere radioembolizationLiver metastasesNeuroendocrine tumorsHepatic tumorsDelayed phasesRadioembolizationTumor densityMedium injectionTumor attenuationTumor vesselsTumorsTheraSphereEmbolic effectCone-beam CTSignificant decrease